Telix Pharmaceuticals (TLX) stock

Cancer radiopharmaceuticals , market cap $3.2B

Cancer radiopharmaceuticals

Worth $3.2B

$9.45

-4.45%

As of Tuesday's close · Live for Pro members at the open

Why is TLX down?

Down 4.4% today, more than its biotech peers' 1.4%; no story names it yet.

Rose on Oct 29

Up 3% on Oct 29, and still 7% over its Oct 28 close.

Telix Pharmaceuticals rose 3% that day while biotech stocks were flat: it beat its group by 3 points.

Sources: Price history, Oct 29, 2026

Tell me next time TLX moves

Free account, no card. An optional alert when TLX moves or its score changes.

Or see it live, free until Thursday morning. No account.

1 more reason, free with an account →The timeline and its peers, for Pro members.

Quality Score

Below Average

In its industry

#123of 281

Biotech

Checks firing

2of 14

Transition

From 52-week high

-27.9%

under its best in a year

TLX's Quality Score fell 1 point on Tue, Nov 10, to 1. It closed away from its high of the day (2 chart checks stopped).

Follow TLX's trial news. Pro members can get an alert when Telix Pharmaceuticals files news, and see its trials, share raises, and its CEO's filings.

Get an alert when TLX files news on its trialsSee it live, free until Thursday morning. No account. No card. Then keep going with a free account.

We do the work for you. Every stock is scored and ranked, every 15 seconds while the market is open. Here it's 15 minutes behind. Pro members see it live.

Next2026“Resubmission to the FDA is planned in the near term and remains a top priority for the Company in 2026.”Filing with regulators · SEC filing · Oct 21

Key facts on TLX

Key facts on TLX
Since its 2025 high	Down 53% profit $33.7M → a $7.1M loss a year
Latest filing	6-K, Oct 21 Issued a release: "Telix Reports Third Quarter 2026 Financial Performance Melbourne (Australia) and Indianapolis, IN (U.S.) – October 21, 2026. Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, “Telix”) provides…"

1 more reason behind TLX's 1, free with an account →1 more reason behind TLX's 1, for Pro members.

TLX in the news

TodayNo story names it yet.

TLX catalysts

Coming up

3 more coming up and 5 past catalysts since 2026, with sizes and sources, for Pro members.

What's next for TLX, and how long its cash lasts

Next step the company has named

2026“Resubmission to the FDA is planned in the near term and remains a top priority for the Company in 2026.”Filing with regulators · SEC filing · Oct 21

What it means: a filing asks regulators to approve a drug for sale. Once it is complete and accepted, the FDA sets a decision date, and we show it here.

A trial underway: BiPASSPhase 3 · Active · 338 people · main data estimated Jan 2027 · NCT07052214

9 more trials, 2 more milestones and 63 filings, for Pro members.

Cash runway Dec 31, 2025 balance sheet

$142M in cash

Fewer than four quarters of cash flow are on file.

What it means: a runway is counted only when each of the last four quarters used cash.

For Pro members: the cash used each quarter, and the math.

Dilution on the horizon

Shelf registration (F-3ASR, filed Feb 20, 2026)
At-the-market share sales program (F-3ASR, filed Feb 20, 2026)

For Pro members: the amounts, and the share count against a year ago.

Insiders

CFO Darren Charlton Smith bought 2,071 shares on Sep 7. 1 more insider trade this year.

From Form 4: open-market buys and sales only.

Get an alert when Christian Behrenbruch buys or sells

For Pro members: every trade, and Christian Behrenbruch’s 5 filings and quotes.

Get an alert when TLX files news on its trialsA free account. No card.

See every upcoming FDA date →

FDA dates in the next 60 days

Decision dates and advisory committee meetings the companies have announced in their filings, soonest first and small companies first.

DateStockDrug

In 12 daysFDA decisionIn 12 days · FDA decisionCAPRCapricor TherapeuticsDeramiocelCAPRCapricor Therapeutics · $500MDeramiocelFDA decision due (PDUFA)
In 12 daysFDA decisionIn 12 days · FDA decisionSVRASavaraMolgramostimSVRASavara · $900MMolgramostimFDA decision due (PDUFA)
In 42 daysFDA decisionIn 42 days · FDA decisionMLYSMineralys TherapeuticsLorundrostatMLYSMineralys Therapeutics · $1.3BLorundrostatFDA decision due (PDUFA)

14 more FDA dates and 103 trial data dates in the next 60 days, each on the FDA calendar. Pro members see whether each company's cash lasts past its date, with an optional alert before it. See all 151 dates, ranked →

Why TLX scores 1

Below Averagefor quality, not price, 2 of 14 chart checks firingWhat the Quality Score means

+2Chart checks 2 of 14 firing right now, one point each
−1Long-term trend below a falling 200-⁠day average

Profit subtractsRead on the last four quarters against the four before, or the last full year where no quarters are filed.
News adds

No effect today: Run-up, Size, Growth, Dilution, Volatility, Cash flow, and Persistence.

What every line is worth, and the reason behind it, on TLX and every other stock.Get in free →

Price, score, chart checks, and the industry rank are from a snapshot taken at 11:29 PM ET, at least 15 minutes behind. How we rank stocks.

Tested. Our top-scored stocks returned 2.2x the average stock over the next month. Reconstructed after the fact; recorded live since Sep 9, 2026. How we tested it

How TLX ranks in Biotech

TLX is #123 of 281 by Quality Score.

How TLX ranks in Biotech
Rank	Stock	Checks	Quality Score
1	ONCBeOne Medicines	8/14	24
2	VCELVericel	8/14	22
3	ETONEton Pharmaceutcials	9/14	20
	TEVATeva Pharmaceutical Industries		Open for its score
	TGTXTG Therapeutics		Open for its score
	TNGXTango Therapeutics		Open for its score
	TNXPTonix Pharmaceuticals		Open for its score
123	TLXTelix Pharmaceuticals	2/14	1

TLX sales and profit by year

Sales and profit by year

Sales grew every year from 2023 to 2025, to $804M. It lost money in 2025 after a profit in 2024.

TLX has 2 of 14 chart checks firing

Trend1 of 5 shown

MA FAN 21 EMA W.EMA HH/HL 52W HI

Volume1 of 3 shown

VOL VDU U/D VOL

Tight range1 of 3 shown

ATR SQZ SQUEEZE NR7

Buying1 of 3 shown

OBV+CLOSE HI SPRING

The other 10 checks on TLX, and all 14 on every stock.Get in free →

TLX RSI today: 43.3, below its 50-day and 200-day averages

Not scored

RSI 43.3, MACD above signal, below both averages. Not scored.13 readings

The deep dive on TLX

What it does and how it makes money4 findings"We are also eligible to receive single-digit percentage royalties on net sales of therapeutics products in the Grand Pharma Territory for ten years after marketing authorization is granted in the Grand Pharma Territory." (20-F for fiscal 2025)SEC filing · Feb 20, 2026
Where it stands1 findingFor Pro members1 finding on where TLX stands: its cash, debt, and share count, for Pro members
What changed in its filings5 findings"On June 6, 2023, Merck filed a lawsuit against HHS and CMS asserting that, among other things, the IRA’s Drug Price Negotiation Program for Medicare constitutes an uncompensated taking in violation of the Fifth Amendment of the Constitution." (20-F for fiscal 2025)SEC filing · Feb 20, 2026New in its "Risk Factors" this year: "Our main competitors also include companies developing PSMA-targeted therapies, including AstraZeneca PLC, Convergent Therapeutics, Inc., Eli Lilly & Company Ltd., Lantheus Holdings, Inc., Curium Holding SAS, ArtBio, Inc., The Bracco Group (through its Blue Earth Therapeutics Ltd. Subsidiary) …" (20-F for fiscal 2025)SEC filing · Feb 20, 2026
Who holds and trades it2 findingsFor Pro members2 findings on who holds and trades TLX, for Pro members
Against its closest peers2 peersFor Pro membersTLX against 2 peers, fact by fact, for Pro members

9 more findings on TLX, each with its source, for Pro members.

TLX share count over time

Shares of TLX outstanding, as filed
Shares outstanding	As of
338.8M	Dec 31, 2025
334.7M	Dec 31, 2024

Offerings, shelves, and splits of TLX, from its filings
From its filings	Filed
Registered shares for a later sale (F-3ASR)	Feb 20, 2026
Registered shares for sale (F-1)	May 17, 2024

TLX's officers and directors

Officers and directors with a Form 4 in the last 12 months.

Christian BehrenbruchMD & Group CEO · 2 trades
Darren Charlton SmithGroup Chief Financial Officer · no trades on file

See insider trades by person

About Telix Pharmaceuticals

Telix is a developer of radiopharmaceuticals. Radiopharmaceuticals are specialized drugs containing radioactive isotopes, which are used in both diagnosing and treating cancer. At low doses, these drugs bind to a specific cancer cell and can be visualized through PET imaging. With high doses, they can deliver targeted treatment. Telix has a pipeline of both diagnostics and therapeutics in development. Its pipeline is focused on urologic oncology (prostate, kidney and bladder), neuro-oncology (glioma), musculoskeletal oncology and hematology. Currently, most of the firm's revenue comes from its Illuccix prostate cancer imaging/diagnostic agent.

1,184 employeestelixpharma.com

What Telix Pharmaceuticals says it competes with

“Our potential competitors include all entities developing and commercializing diagnostics and therapies in the field of oncology, through nuclear medicine and other modalities.”

From its annual report, SEC filing · Feb 20, 2026

Here is what Pro members see.

The same page for Pro members, on Microsoft
Its Quality Score and rank, the line that drives it, and the live price.
The full chart
A year of candles to start, out to the whole history, with insider trades marked and the Quality Score under the price.
Every line of the score
Price action, the company, and signals, each with its points, on TLX and every other stock.
FDA dates, counted down
Each date in the company's words, its cash against the date, and an optional alert before it.
CEOs buying their own stock
Every CEO buy, biggest names first. Sort, filter, save the list, and set optional alerts.
Congress trades
A member's trades, newest first, each with its amount. Sort and filter the whole list.
14 chart checks, read for you
The ones firing on the stock, each in plain words, its rule a tap away.
Earnings, week by week
Who reports each day, and how each stock took its last four reports.
The market map
Every stock a box, colored by its Quality Score.
Themes, ranked live
Each theme's stocks ranked by Quality Score, live. Here, AI chips.
The top 10, every day
The ten highest Quality Scores at each close, kept day by day, week by week.
Optional alerts, your way
Pick a stock, a score, a price, a filing, or a whole scan. It tells you by push or email.
Your watchlist, scored
Your stocks by Quality Score, today's move, or name.
On your phone and your laptop
The same account and watchlist on both, each laid out for its screen.

Prices refresh every 2.5 seconds during market hours.
Optional alerts by push, email, or the bell.
Add it to your Home Screen and it opens like an app.

Pro members see every line of every stock's score.

What would turn TLX's score around: 5 things
5 more filings explained, a plain line each
Real-⁠time prices, no delay

See TLX's 14 chart checks

See it live, free until Thursday morning. No account. No card. Then keep going with a free account.

Straight AnswersStraight Answers

As of Nov 10, 2026: TLX's Quality Score is 1 (Below Average), #123 of 281 in Biotech.

What does TLX's Quality Score say?

TLX scores 1 today, which Breakaway calls Below Average. It is #123 of 281 in Biotech by Quality Score, with 2 of 14 chart checks firing. Up 3% on Oct 29, and still 7% over its Oct 28 close. Breakaway does not say whether to buy any stock: the score does not know your situation, and it is not a recommendation to buy or sell anything. Please do your own research.

What is TLX's Quality Score?

TLX scores 1 today, which Breakaway calls Below Average (0 to 5). That is #123 of 281 in Biotech by Quality Score. The score adds up the chart checks, the trend, the company's filed sales, its profits, the news, insider trades, and Congress trades. The section above lists the lines behind TLX's 1.

Are the prices delayed?

Only on the public pages, which run at least 15 minutes behind. Pro members, and anyone on a guest pass, see real-time prices: the scanner refreshes every 15 seconds, and your watchlist every few seconds, pre-market and after hours included.